Morris and Dickson
Morris & Dickson is the largest independently owned US full-line and specialty pharmaceutical distributor, distributing brand, generic, and specialty drugs to health systems, independent pharmacies, specialty pharmacies, clinics, and infusion centers across all 50 states, with over $7 billion in annual sales.
- Company typePrivate
- Founded1841
- HeadquartersShreveport, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Morris and Dickson does
Morris & Dickson Co., LLC is the largest independently owned full-line and specialty pharmaceutical distributor in the United States, founded in 1841 and headquartered in Shreveport, Louisiana. The company distributes brand-name drugs, generics, plasma-derived therapies, biologics, biosimilars, vaccines, OTC products, and home health supplies to health systems, independent pharmacies, specialty pharmacies, physician-owned clinics, infusion centers, and alternate care facilities across all 50 states, reporting more than $7 billion in annual sales and offering over 30,000 SKUs from a single location.
Operations are anchored by a 450,000-square-foot automated distribution center in Shreveport and a second 97,200-square-foot facility under development in Olive Branch, Mississippi, with over 90% of order lines picked through automation at a 1-in-60,000 error rate and an owned fleet traveling 150,000+ miles per day for next-day delivery. Advanced cold chain capabilities span storage down to -80°C using Aerosafe Global and Coldtainer systems with real-time temperature monitoring, supported by 46,400 cubic feet of secured Bio Box specialty storage and over 1,200 cold locations. Customer-facing technology includes the Prodigy Vision portal for real-time inventory and ordering, Prodigy Connect RFID/IntelliGuard smart-cabinet consignment monitoring, Prodigy 360 DSCSA compliance tooling, and the Cervey technology platform for 340B program management.
The business model combines wholesale pharmaceutical distribution (transaction-fee revenue), specialty distribution of limited-distribution drugs and biologics, third-party logistics services for manufacturers via PresaMD, and a specialty GPO (BeaconMD) providing transparent drug purchasing for clinics and infusion centers. Recent acquisitions of Presa Solutions (2025) and Prodigy Health (2026), a Johnson & Johnson specialty-drug supply agreement, and a partnership with Mark Cuban Cost Plus Drug Company extend the platform into 3PL services, plasma-derived therapies, and direct injectables distribution. Distribution is NABP-accredited and HDA-affiliated, with a dedicated account-specialist sales model serving the pharmacy and healthcare-provider market.
Morris and Dickson firmographics
Firmographics- Name
- Morris and Dickson
- Legal name
- Morris & Dickson Co. LLC
- Website
- https://morrisdickson.com
- Company type
- Private
- Founded year
- 1841
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Morris & Dickson is the largest independently owned US full-line and specialty pharmaceutical distributor, distributing brand, generic, and specialty drugs to health systems, independent pharmacies, specialty pharmacies, clinics, and infusion centers across all 50 states, with over $7 billion in annual sales.
- Ownership category
- akta.pro rank
Morris and Dickson industry classification
Industry- Product category
- Pharmaceutical Wholesale Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Full-Line Pharmaceutical Wholesalers (HLAIAJAA)
- akta.pro secondary industries
- Specialty Pharmaceutical Distributors (HLAIAJAB), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
Keywords
Where Morris and Dickson is headquartered
LocationHeadquarters
- HQ city
- Shreveport
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Morris and Dickson business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales, Others
Revenue model
- Full-Line Pharmaceutical Distribution: Distribution of brand name drugs, generics, OTC products, and home health products to health systems, independent pharmacies, specialty pharmacies, and alternate care facilities across the United States.
- Specialty Pharmaceutical Distribution: Distribution of limited distribution drugs (LDDs), exclusive drugs, plasma-derived therapies, biologics, biosimilars, and specialty medications requiring cold chain handling to qualified institutional, hospital, and specialty retail pharmacies.
- Third-Party Logistics (3PL) Services: Order management, invoicing, deductions management, full financial reporting, contract and chargeback administration, flash title distribution, and DSCSA preparedness for pharmaceutical manufacturers through PresaMD.
- Specialty GPO Services: Group purchasing organization services through BeaconMD providing transparent drug purchasing models and competitive contract pricing for specialty clinics and infusion centers.
- Specialty Injectable Distribution Partnership: Partnership with Mark Cuban Cost Plus Drug Company to distribute injectable medications, ensuring steady availability of rare drugs and lower costs for healthcare providers.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels3 records
Morris and Dickson product offering
Product offeringCore offering
Morris & Dickson is the largest independent full-line and specialty pharmaceutical distributor in the United States, providing next-day delivery of brand name, generic, specialty, plasma/biologic, biosimilar, vaccine, OTC, and home health products to health systems, independent pharmacies, specialty pharmacies, clinics, infusion centers, and alternate care facilities. The company also provides specialty GPO services through BeaconMD, third-party logistics (3PL) services for pharmaceutical manufacturers through PresaMD, and technology solutions (340B, DSCSA, inventory) through Cervey and the Prodigy suite.
Product overview
Morris & Dickson is the largest independent full-line and specialty pharmaceutical distributor offering reliable next-day delivery of drugs and related products. The core offering centers on the M&D Web Portal for ordering and the M&D Specialty Distribution (MDSD) platform with advanced cold chain capabilities. The product portfolio includes Brand Name pharmaceuticals, Generics, Plasma & Biologics, Biosimilars, Vaccines, OTC products, and Home Health items distributed to health systems, independent pharmacies, specialty pharmacies, physician-owned clinics, infusion centers and alternative care facilities. The company operates several subsidiary brands: ProdigyMD (acquired specialty distributor focused on plasma-derived therapies with Prodigy Vision Portal, Prodigy Connect RFID, Prodigy OnDemand consignment, and Prodigy 360 DSCSA compliance), BeaconMD (specialty Group Purchasing Organization for clinics and infusion centers), PresaMD (acquired 3PL services for order management and chargeback administration), and Cervey (technology solutions for 340B program management and DSCSA data management). The company holds over 30,000 pharmaceutical and healthcare SKUs from a single location, with expansion of specialty handling capacity including dedicated refrigerated areas and Aerosafe/Coldtainer cold chain capabilities.
Differentiator
Problem solved
Functional benefit
Products and services
- Full-Line Pharmaceutical Distribution Wholesale distribution of brand name drugs, generic drugs, OTC products, and home health products to health systems, independent pharmacies, specialty pharmacies, and alternate care facilities across the United States, with next-day delivery from a single 450,000-square-foot automated distribution center.
- Specialty Pharmaceutical Distribution (M&D Specialty Distribution / MDSD) Distribution of limited distribution drugs (LDDs), exclusive drugs, plasma-derived therapies, biologics, biosimilars, and specialty medications requiring cold chain handling (down to -80°C) to qualified institutional, hospital, and specialty retail pharmacies, supported by 46,400 cu. ft. of secured cold storage and ultra-cold chain capability.
- Plasma-Derived Therapies Distribution (ProdigyMD) Specialty pharmaceutical distribution of plasma-derived therapies (IVIG, Albumin, Hyperimmune Globulin, Coagulants, Hemophilia Factor) to hospitals, specialty pharmacies, infusion centers, and clinics, delivered through the ProdigyMD portal with same-day delivery and consignment services.
- Specialty GPO Services (BeaconMD) Specialty Group Purchasing Organization connecting specialty pharmacies, independent specialty clinics, and infusion providers to therapies, pricing, and support across immunology, oncology, neurology, gastroenterology, and rare disease therapeutic areas, with competitive contract pricing and access to limited distribution products.
- Third-Party Logistics Services (PresaMD) Third-party logistics services for pharmaceutical manufacturers including order management, invoicing, collections, deductions management, financial reporting, contract and chargeback administration, flash title distribution, and DSCSA preparedness through the PresaMD order-to-cash platform.
- Consignment Services Consignment inventory programs that allow healthcare facilities to stock specialty medications without upfront purchase, reducing waste, eliminating expiry risk, and improving availability of high-cost variable-use drugs.
- Generic Sourcing Program Dynamic generics sourcing program utilizing RFP practices to review items, increase savings, and expand portfolio options, providing access to cost savings directly from manufacturers on a dynamic portfolio of generic drugs.
- Secondary Distribution Services Distribution services supporting secondary sales and fulfillment for pharmaceutical manufacturers beyond primary distribution channels, including support for the planned Olive Branch, MS distribution center focused on secondary distribution.
- Technology Solutions (Cervey) Technology solutions for health systems, specialty pharmacies, and sites of care covering 340B program management, DSCSA data management, and workflow optimization tools.
- 503B Outsourced Compounding Services Sales, service, and distribution partnership providing compounded sterile preparations from an FDA-registered 503B outsourcer (Leiters) to health systems and specialty pharmacies.
- Brand Name Pharmaceuticals Full portfolio of brand-name pharmaceutical products distributed to health systems, pharmacies, and care facilities.
- Generic Pharmaceuticals Generic pharmaceutical products with competitive pricing and extensive inventory from the centralized Shreveport distribution center.
- Plasma & Biologics Plasma-derived products and biologics including IVIG, Albumin, Hyperimmune Globulin, Coagulants, and Hemophilia Factor distributed through ProdigyMD.
- Biosimilars Biosimilar pharmaceutical products offering cost-effective alternatives to reference biologics.
- Vaccines Vaccine products distributed across the United States including routine immunizations and specialty vaccines with cold chain handling.
- Over the Counter (OTC) Over-the-counter pharmaceutical and healthcare products for retail pharmacy distribution.
- Home Health Products Products and supplies for home healthcare settings and home-based patient care.
Quantifiable outcome
- Error rate of 1 in 60,000 through automation, significantly better than industry rate of 1 in 6,000
- +3 more outcomes
Companies that use Morris and Dickson
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
Morris and Dickson technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Morris and Dickson partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and strategic.
- Prodigy Health (now ProdigyMD)coreAcquisition completed in January 2026. Prodigy Health is a specialty pharmaceutical distribution company focused on plasma-derived therapies. The acquisition strengthens Morris & Dickson's specialty portfolio and expands ability to serve alternative sites of care including hospitals, specialty pharmacies, clinics, and infusion centers nationwide. Prodigy Health operates under the name ProdigyMD.
- Presa SolutionsstrategicAcquisition of virtual third-party logistics (3PL) provider for pharmaceutical manufacturers. The acquisition integrates Presa Solutions' innovative order-to-cash platform with Morris & Dickson's existing logistics network, supporting biotech and pharmaceutical clients. Now operating as PresaMD.
- Johnson & JohnsonstrategicAgreement to expand specialty distribution portfolio by adding over 50 new specialty drugs including Darzalex, Stelara, Remicade, Simponi, Tremfya, Zytiga, Invega, Monovisc, Orthovisc, Procrit, Risperdal, and Xarelto. Enhances company's ability to support oncology, rheumatology, and rare disease treatments.
- BeaconMDcoreFive-year, non-exclusive distribution agreement where BeaconMD (a GPO) brings high-value drug pricing programs to community sites of care nationwide. Morris & Dickson supports BeaconMD members with next-day fulfillment services of specialty products, including cold chain packaging through Aerosafe Global.
- Mark Cuban Cost Plus Drug Company (MCCPDC)corePartnership established in 2024 to improve access to injectable medications and supply chain efficiency. The partnership aims to ensure steady availability of rare drugs and lower costs for healthcare providers. Morris & Dickson serves as a specialty pharmaceutical distributor partner for MCCPDC's injectable medication portfolio.
- PfizerstrategicPharmaceutical supplier partner for specialty distribution portfolio. Part of contracts with significant pharmaceutical suppliers including Johnson & Johnson, Pfizer, and Genentech.
- GenentechstrategicPharmaceutical supplier partner for specialty distribution portfolio. Part of contracts with significant pharmaceutical suppliers including Johnson & Johnson, Pfizer, and Genentech.
- Aerosafe GlobalstrategicCold chain packaging solution provider for temperature control and tracking throughout pharmaceutical payload journey. Ensures patient safety and reduces packaging waste.
Scale indicators12 records
Recent moves8 records
Expansion highlights7 records
Morris and Dickson competitors and assessment
Company assessmentDirect peers
- McKesson Corporation: McKesson is the largest U.S. pharmaceutical distributor with full-line and specialty distribution across branded, generic, and specialty products. It directly competes with Morris & Dickson for health systems, retail pharmacies, and specialty distribution contracts, though at far greater scale.
- Cencora (formerly AmerisourceBergen): Cencora is one of the Big 3 U.S. pharmaceutical distributors and a major player in specialty distribution (through its US Bioservices and Specialty Provider Services). It competes directly with Morris & Dickson's full-line and specialty businesses for manufacturer contracts and downstream pharmacy/health-system customers.
- Cardinal Health: Cardinal Health operates one of the largest U.S. pharmaceutical and medical product distribution networks, including specialty distribution (Cardinal Health Specialty Solutions). It is a direct competitor to Morris & Dickson in serving retail pharmacies, hospitals, and specialty providers nationwide.
- Smith Drug Company: Smith Drug Company is a privately held full-line pharmaceutical wholesaler serving independent and regional pharmacy customers. It is the closest independent analog to Morris & Dickson in terms of customer focus (independents and regionals) and absence of Big 3 ownership.
- Anda, Inc. Anda is Teva's U.S. pharmaceutical distribution business, distributing generic, brand, and specialty products to retail pharmacies, hospitals, and alternate care sites. It is comparable as a specialty/generic-capable distributor competing for similar end customers.
- BioCareSD: BioCareSD is an independent specialty pharmaceutical distributor focused on limited distribution drugs, plasma/bio products, and specialty therapies to specialty pharmacies and providers. It is directly comparable to Morris & Dickson's MDSD and ProdigyMD specialty operations.
Broad incumbents
- ClarusONE Sourcing Services: ClarusONE is a joint venture between Walmart and McKesson that negotiates generic procurement at scale. It is comparable as a competitor in generic sourcing/wholesale that pressures independent distributors like Morris & Dickson on generics economics.
Regional players
- Mutual Drug Company: Mutual Drug is an independent regional pharmaceutical wholesaler serving member pharmacies across the Southeastern United States. It overlaps with Morris & Dickson's traditional south-central footprint and independent pharmacy customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Morris and Dickson social profiles
Digital presenceMorris and Dickson compliance and trust
Trust signalCompliance3 records
Morris and Dickson financial estimates
Financial estimateRevenue estimate
Valuation estimate
Morris and Dickson leadership team
Management profileNumber of profiles
Profiles12 records
Morris and Dickson subsidiaries and ownership
Company hierarchySubsidiaries4 records
Morris and Dickson funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Morris and Dickson M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Morris and Dickson
What does Morris and Dickson do?
Morris & Dickson is the largest independent full-line and specialty pharmaceutical distributor in the United States, providing next-day delivery of brand name, generic, specialty, plasma/biologic, biosimilar, vaccine, OTC, and home health products to health systems, independent pharmacies, specialty pharmacies, clinics, infusion centers, and alternate care facilities. The company also provides specialty GPO services through BeaconMD, third-party logistics (3PL) services for pharmaceutical manufacturers through PresaMD, and technology solutions (340B, DSCSA, inventory) through Cervey and the Prodigy suite.
Is Morris and Dickson a public or private company?
Morris and Dickson is a private company. It is classified as family owned and is currently operating.
When was Morris and Dickson founded?
Morris and Dickson was founded in 1841. It employs 251 to 500 people.
Where is Morris and Dickson based?
Morris and Dickson is headquartered in Shreveport, United States, in the North America region.
How does Morris and Dickson make money?
Five revenue lines are on record. Full-Line Pharmaceutical Distribution is the primary driver. The others are specialty Pharmaceutical Distribution, third-Party Logistics (3PL) Services, specialty GPO Services and specialty Injectable Distribution Partnership.
Who are Morris and Dickson's main competitors?
Direct peers on record are McKesson Corporation, Cencora (formerly AmerisourceBergen), Cardinal Health, Smith Drug Company, Anda, Inc. and BioCareSD. ClarusONE Sourcing Services is listed as a broad incumbent. Mutual Drug Company is listed as a regional player.
Does Morris and Dickson have an API?
No public API is recorded for Morris and Dickson.
What industry is Morris and Dickson in?
Morris and Dickson's product category is Pharmaceutical Wholesale Distribution. Its primary akta.pro industry code is HLAIAJAA, Full-Line Pharmaceutical Wholesalers, with a secondary code of HLAIAJAB, Specialty Pharmaceutical Distributors. Its NAICS code is 42421 and its SIC code is 5122.